Biotech research company Qvin has announced the FDA clearance of its innovative Q-Pad and A1c Test, marking a significant advancement in women’s health technology. This approval introduces a new method of health monitoring for millions of American women, particularly those living with diabetes, through menstrual blood testing. The Q-Pad offers a less invasive and more accessible alternative to traditional venous blood draws.…
![](https://femtechinsider.com/wp-content/uploads/2024/01/qvin-1144x658.png)